Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Treatment/Intervention:  CAM biologically-based therapy, CAM exercise therapy, CAM immunoaugmentative therapy, CAM nutritional therapy, CAM pharmacological or biological treatment, CAM procedure, CAM therapy
Results 1-25 of 73 for your search:
Start Over
Acupuncture in Treating Dry Mouth Caused by Radiation Therapy in Patients with Head and Neck Cancer
Status: Active
Phase: Phase III
Type: Supportive care
Age: Not specified
Trial IDs: MDA-04-01, NCI-2011-02073, WFU 97115, CDR0000674208, WF-97115, NCT01141231
Yoga, Survivorship Health Education, and Cognitive Behavioral Therapy in Reducing Insomnia in Cancer Survivors
Status: Active
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: URCC14040, NCI-2015-01144, RSRB052271, NCT02613364
Physical Activity in Reducing Functional Health Disparities in Older Stage I-III Breast Cancer Survivors
Status: Active
Phase: Phase III
Type: Supportive care
Age: 65 and over
Trial IDs: CASE2116, NCI-2016-01773, NCT02763228
Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness)
Status: Active
Phase: Phase III
Type: Supportive care
Age: 49 and under
Trial IDs: 16-000817, NCI-2016-01396, NCT03025139
Irinotecan Hydrochloride with or without Chinese Herbal Formulation PHY906 in Treating Patients with Metastatic Colorectal Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UPCI 12-005, NCI-2016-00749, NCT00730158
Acupuncture or Gabapentin in Treating Breast Cancer Survivors With Hot Flashes
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: UPCC 16108, NCI-2009-01315, NCT01005108
Genistein in Reducing the Toxicity and Improving the Efficacy of Bacillus Calmette Guerin Intravesical Therapy in Patients with Bladder Cancer
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: EU2010-11, NCI-2014-02088, IRB00050273, NCI-2014-02072, NCT01489813
Food Insecurity Interventions in Improving Treatment Completion in Patients with Cancer Undergoing Chemotherapy or Radiation Therapy
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 12-099, NCI-2016-01753, NCT01603316
Curcumin in Reducing Fatigue in Patients with Chemotherapy-Treated Breast Cancer Undergoing Radiotherapy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18
Trial IDs: WINSHIP2139-11, NCI-2014-02195, IRB00055328, NCT01740323
Calcitriol before Surgery in Preventing Calcium Loss in Patients Undergoing Thyroidectomy
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: TC-P2-CALCITRIOL, NCI-2014-00962, NCT01868750
Omega-3 Fatty Acid in Treating Patients with Stage I-III Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCCWFU 98113, NCI-2013-00963, NCT01869764
Curcumin in Treating Patients with Prostate Cancer That Was Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 to 80
Trial IDs: 042013-080, NCI-2014-01511, CR00008417, Mod6_STU 042013-080, NCT02064673
Efficacy, Safety and Pharmacokinetics Study of Antroquinonol to Treat NSCLC
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GHNSCLC-2 001, NCI-2014-02209, NCT02047344
Transcranial Direct Current Stimulation and Cognitive Training in Improving Cognitive Function in Adult Survivors of Childhood Acute Lymphoblastic Leukemia
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: ALLSTIM, NCI-2015-00050, NCT02336282
High-Dose Ascorbic Acid, Temozolomide, and Radiation Therapy in Treating Patients with Glioblastoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 201504786, NCI-2017-00716, NCT02344355
A Mouth Rinse Containing East Indian Sandalwood Oil (EISO) for the Prevention and Treatment of Oral Mucositis
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: SAN005-01, NCI-2015-02029, NCT02399228
Hypnotherapy and Relaxation Therapy in Improving Body, Self-Image and Sexuality in Patients with Breast or Gynecologic Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 21 and over
Trial IDs: UMCC 2015.081, NCI-2016-00036, HUM00100709, NCT02531997
Noni Extract in Treating Patients with Very Low Risk or Low Risk Prostate Cancer Undergoing Active Surveillance
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 60 and over
Trial IDs: Huang-2015-1, NCI-2016-00082, NCT02648919
Electroacupuncture Therapy in Reducing Chronic Pain in Patients with Stage I-III Breast Cancer and Post-mastectomy Pain Syndrome
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 2015-0750, NCI-2016-00792, NCT02754752
Selinexor with Induction, Consolidation, and Maintenance Therapy in Treating Older Patients with Acute Myeloid Leukemia
Status: Active
Phase: Phase II
Type: Treatment
Age: 60 and over
Trial IDs: CCCWFU 22316, NCI-2016-00951, NCT02835222
Efficacy of Ginseng for Patients on Regorafenib
Status: Active
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: HCRN GI14-191, NCI-2017-00218, NCT02581059
Defined Green Tea Catechin Extract and Erlotinib Hydrochloride in Treating Patients with Premalignant Lesions or Previously Treated Early Stage Squamous Cell Cancer of the Head and Neck
Status: Active
Phase: Phase I
Type: Prevention
Age: 18 and over
Trial IDs: WCI1549-08, NCI-2011-03396, WCI 1549, IRB00014010, NCT01116336
Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
Status: Active
Phase: Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: CTAP101-CL-1017, NCI-2015-01720, NCT02274623
Qigong Mind-Body Exercise in Treating Persistent Post-Surgical Pain in Breast Cancer Survivors
Status: Active
Phase: Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: 15-347, NCI-2016-01199, NCT02848989
Bevacizumab and Ascorbic Acid in Patients Treating with Recurrent High Grade Glioma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 19 and over
Trial IDs: 769-15, NCI-2016-00239, 769-15-FB, NCT02833701
Start Over